Безопасен ли oligopeptide-17 при беременности?

Pregnancy-safe products containing oligopeptide-17

Perricone MD

Perricone MD Neuropeptide Face Activator

83/100

Related ingredients

Frequently asked questions

Безопасен ли oligopeptide-17 при беременности?

No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment was identified for 'oligopeptide-17'. No peer‑reviewed reproductive or developmental toxicity data specific to this ingredient were found in PubMed, and peptides of this size used topically are generally polar with low dermal absorption (CosIng / PubChem data lacking specific absorption evidence). Therefore default score is 0 for hazard and mechanism, and exposure is considered negligible for topical cosmetic use.

Безопасен ли oligopeptide-17 при грудном вскармливании?

No data indicating reproductive or lactation hazards (no ECHA harmonised H361/H360, no CIR/SCCS opinion). Topical oligopeptides are expected to have minimal systemic bioavailability; no evidence was found that they concentrate in milk or pose a hazard to breastfeeding infants.

Безопасен ли oligopeptide-17 для кожи малыша?

Hazard and mechanism: no specific reproductive/developmental/infant toxicity data identified (h=0, m=0). Exposure: increased to 1 for infants (0–3 yr) because immature skin barrier and higher surface‑area‑to‑weight can raise per‑kg exposure even for ingredients with low adult absorption; no data were found demonstrating significant dermal absorption for oligopeptide‑17 to justify higher exposure scoring.

Как VeriMom оценивает oligopeptide-17?

VeriMom оценивает oligopeptide-17 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы oligopeptide-17 при беременности?

См. наш список безопасных альтернатив oligopeptide-17 с аналогичной функцией и классификацией без известных рисков.